Cancer stem cells in osteosarcoma: Recent progress and perspective

Acta Oncologica

Volumn 50, Issue 8, 2011, Pages 1142-1150

  Liu, Bin ^a   Ma, Wei ^a   Jha, R K ^a   Gurung, Kiran ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CXCR4; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLICE INHIBITORY PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; MULTIDRUG RESISTANCE PROTEIN 1; NOTCH RECEPTOR; PROTEIN BCL 2; PROTEIN MLH1; PROTEIN MSH2; SONIC HEDGEHOG PROTEIN; STEM CELL FACTOR RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; SURVIVIN; TUMOR MARKER; WNT PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL ISOLATION; CELL KILLING; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CYTOLOGY; DNA REPAIR; HUMAN; METASTASIS; MISMATCH REPAIR; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

ANIMALS; BONE NEOPLASMS; HUMANS; NEOPLASTIC STEM CELLS; OSTEOSARCOMA;

EID: 80155187103     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.584553     Document Type: Review

References (72)

1. Makino S. The role of tumor stem-cells in regrowth of the tumor following drastic applications. Acta Unio Internationalis Contra Cancrum 1959;15:196-8.
2. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identifi cation of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8.
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identifi cation of human brain tumour initiating cells. Nature 2004;432(7015):396-401.
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identifi cation and expansion of human colon-cancer-initiating cells. Nature 2007;445(7123):111-5.
6. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodefi cient mice. Nature 2007;445(7123):106-10.
7. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identifi cation of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-51.
8. Li CW, Heidt DG, Dalerba P, Burant CF, Zhang LJ, Adsay V, et al. Identifi cation of pancreatic cancer stem cells. Cancer Res 2007;67:1030-7.
9. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Signifi cance of CD90(-) cancer stem cells in human liver cancer. Cancer Cell 2008;13:153-66.
10. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, et al. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 2005;7:967-76.
11. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Ann Rev Cell Dev Biol 2007;23:675-99.
12. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Mori T, et al. Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas. Biochem Biophys Res Comm 2007;362:773-8.
13. Shackleton M. Normal stem cells and cancer stem cells: Similar and different. Semin Cancer Biol 2010;20:85-92.
14. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M. Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study. J Clin Oncol 2005;23:3742-51.
15. Meyers PA, Krailo M, Grier H, Bernstein M. Prospectively planned analysis of data from a phase III study of liposomal muramyltripeptide phosphatidylethanolamine in the treatment of osteosarcoma - Reply. J Clin Oncol 2005;23:6438-9.
16. Honoki K. Do stem-like cells play a role in drug resistance of sarcomas? Expert Rev Anticancer Ther 2010;10:261-70.
17. Wicha MS, Liu SL, Dontu G. Cancer stem cells: An old idea - A paradigm shift. Cancer Res 2006;66:1883-90.
18. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414(6859): 105-11.
19. Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, et al. Interaction between leukemic-cell VLA-4 and stromal fi bronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003;9: 1158-65.
20. Schofi eld R. Relationship between spleen colony-forming cell and hematopoietic stem-cell-hypothesis. Blood Cells 1978;4:7-25.
21. Chang PY, Bjornstad KA, Chang E, McNamara M, Barcellos-Hoff MH, Lin SP, et al. Particle irradiation induces FGF2 expression in normal human lens cells. Radiat Res 2000;154:477-84.
22. Tisty T, Grossfeld GD, Hayward SW, Olumi AF, Cunha GR, Carroll PR. Carcinoma-associated fi broblasts stimulate tumor progression of initiated human prostatic epithelium. Mol Biol Cell 1999;10:351a - a.
23. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11:69-82.
24. De Toni F, Racaud-Sultan C, Chicanne G, Mansat-De Mas V, Cariven C, Mesange F, et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 2006;25:3113-22.
25. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438(7069):820-7.
26. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100:15178-83.
27. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identifi cation of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8.
28. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206.
29. Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J 2008;175:69-75.
30. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 2009;34: 1381-6.
31. Wang L, Park P, Lin CY. Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther 2009;8:543-52.
32. Zhou S. Isolation and identifi cation of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs. J Huazhong Univ Sei Technol (Med Sci) 2010;30:81-4.
33. Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, Galderisi U, et al. Detection and characterization of CD133(-) cancer stem cells in human solid tumours. Plos One 2008;3:e3469.
34. Adhikari AS, Agarwal N, Wood BM, Porretta C, Ruiz B, Pochampally RR, et al. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res 2010;70:4602-12.
35. Wu CL, Wei QX, Utomo V, Nadesan P, Whetstone H, Kandel R, et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 2007;67:8216-22.
36. Murase M, Kano M, Tsukahara T, Takahashi A, Torigoe T, Kawaguchi S, et al. Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 2009;101:1425-32.
37. Di Fiore R, Santulli A, Ferrante RD, Giuliano M, De Blasio A, Messina C, et al. Identifi cation and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 2009;219:301-13.
38. Levings PP, McGarry SV, Currie TP, Nickerson DM, McClellan S, Ghivizzani SC, et al. Expression of an exogenous human Oct-4 promoter identifi es tumor-initiating cells in osteosarcoma. Cancer Res 2009;69:5648-55.
39. Li HZ, Yi TB, Wu ZY. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells. BMC Cancer 2008;8:135.
40. Reynolds BA, Rietze RL. Neural stem cells and neurospheres - re-evaluating the relationship. Nat Methods 2005;2:333-6.
41. Kotoula V, Papamichos SI, Lambropoulos AF. Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 2008;26:290-1.
42. Gillette JM, Gibbs CP, Nielsen-Preiss SM. Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma. In Vitro Cell Dev Biol - Animal 2008;44:87-95.
43. Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: Markers and models. Nature Rev Cancer 2005;5:591-602.
44. Bernards R, Weinberg RA. Metastasis genes: A progression puzzle. Nature 2002;418(6900):823.
45. Li F, Tiede B, Massague J, Kang YB. Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res 2007;17:3-14.
46. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu WP, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436(7050):518-24.
47. Minn AJ, Kang YB, Serganova I, Gupta GP, Giri DD, Doubrovin M, et al. Distinct organ-specifi c metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005;115:44-55.
48. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-23.
49. Smith MCP, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004;64:8604-12.
50. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432(7015):324-31.
51. Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Progress in the treatment of acute myeloid leukemia. Cancer 2007;110:1900-10.
52. Woodward WA, Sulman EP. Cancer stem cells: Markers or biomarkers? Cancer Metastasis Rev 2008;27:459-70.
53. Honoki K. Do stem-like cells play a role in drug resistance of sarcomas? Expert Rev Anticancer Ther 2010;10:261-70.
54. Song B, Wang YA, Titmus MA, Botchkina G, Formentini A, Kornmann M, et al. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Molecular Cancer 2010;9:96.
55. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009;28:4065-74.
56. Gangemi R, Paleari L, Orengo AM, Cesario A, Chessa L, Ferrini S, et al. Cancer stem cells: A new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 2009;16:1688-703.
57. Honoki K, Fujii H, Kubo A, Kido A, Mori T, Tanaka Y, et al. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Report 2010;24:501-5.
58. McMahon AP. More surprises in the Hedgehog signaling pathway. Cell 2000;100:185-8.
59. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Altaba ARI. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007;17:165-72.
60. Watkins DN, Peacock CD. Hedgehog signalling in foregut malignancy. Biochem Pharmacol 2004;68:1055-60.
61. Hirotsu M, Setoguchi T, Sasaki H, Komiya S. Hedgehog pathway is activated in osteosarcoma and cyclopamine prevents osteosarcoma growth by cell cycle regulation. J Bone Mineral Res 2008;23:301-7.
62. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006;66:7445-52.
63. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006;20:2096-109.
64. Tanaka M, Setoguchi T, Hirotsu M, Sasaki H, Komiya S. Notch pathway is activated in osteosarcoma and inhibitors of gamma-secretase inhibit osteosarcoma growth by cell cycle regulation. J Bone Mineral Res 2008;23:297-301.
65. Cai YP, Mohseny AB, Karperien M, Hogendoom PCW, Zhou GY, Cleton-Jansen AM. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 2010;220:24-33.
66. Sciandra M, Barbieri S, Picci P, Scotlandi K. CD99 inhibits osteosarcoma malignacy by acting through Wnt pathway. Proc Am Assoc Cancer Res Annual Meeting 2009;50:845.
67. Li G-D, Cai Z-D, Zhang Y-Q, Gong H-Y, Tang H,Zhang Q-L. Gene profi ling of MAPK pathway in human osteosarcoma. Zhonghua Zhongliu Zazhi 2009;31:340-5.
68. Ren TT, Guo W, Peng CL, Lu XC, Yang-Yi. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway. Cancer Biol Ther 2010;10:251-7.
69. Liu SL, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063-71.
70. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, et al. A clinical and experimental-study on all-trans retinoic acidtreated acute promyelocytic leukemia patients. Blood 1991;78:1413-9.
71. Haydon RC, Zhou L, Feng T, Breyer B, Cheng HW, Jiang W, et al. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 2002;8:1288-94.
72. Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D, Wicha MS. Cancer stem cells in breast: Current opinion and future challenges. Pathobiology 2008; 75:75-84.